Using capture sequencing, we found CDK12 mutations in 5/124 tumor samples (4% mutation frequency) which is comparable to that originally reported by the TCGA in 2011 (9/316, 3%) and recently reported by Berger and colleagues (21/523, 4%) [53]. The gene discussed is CDK12; the disease is neoplasm.